GI
TXG icon

GAMMA Investing’s 10x Genomics TXG Stock Holding History

GAMMA Investing’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$422K Buy
4,668
+374
+9% +$21.9K 0.01% 797
2026
Q2 		$165K Buy
4,294
+101
+2% +$2.65K 0.01% 1421
2026
Q1 		$89K Buy
4,193
+253
+6% +$5.06K ﹤0.01% 1774
2025
Q4 		$64.3K Buy
3,940
+292
+8% +$4.41K ﹤0.01% 1896
2025
Q3 		$42.6K Sell
3,648
-39
-1% -$509 ﹤0.01% 2104
2025
Q2 		$42.7K Buy
3,687
+101
+3% +$921 ﹤0.01% 2027
2025
Q1 		$31.3K Buy
3,586
+1,614
+82% +$20.3K ﹤0.01% 2124
2024
Q4 		$28.3K Buy
1,972
+427
+28% +$6.74K ﹤0.01% 2080
2024
Q3 		$34.9K Buy
1,545
+1,265
+452% +$26.2K ﹤0.01% 1744
2024
Q2 		$5.45K Sell
280
-292
-51% -$7.65K ﹤0.01% 2543
2024
Q1 		$21.5K Sell
572
-270
-32% -$11.9K ﹤0.01% 1607
2023
Q4 		$35.1K Buy
+842
New +$36.6K 0.01% 1125

Other funds holding TXG

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

GAMMA Investing's TXG Position: Q3 2026 in Review

GAMMA Investing increased its 10x Genomics (TXG) stake by 8.7% in Q3 2026, buying an estimated $21.9K and bringing the position to 4,668 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #797.

GAMMA Investing first reported a position in TXG in Q4 2023 and has held it in 12 quarters since. 9 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • GAMMA Investing held 4,668 shares of 10x Genomics worth $422K as of Q3 2026.
  • GAMMA Investing bought 374 10x Genomics shares in Q3 2026, an estimated $21.9K.
  • 10x Genomics made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #797 holding.
  • GAMMA Investing first reported a position in 10x Genomics in Q4 2023 and has held it in 12 quarters since.
  • 9 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.